Scientists discovered QT12 gene system in rice that doubles crop yields under heat stress, offering breakthrough solution for food security as global temperatures rise and threaten agricultural production worldwide.
Researchers have successfully sequenced the first complete ancient genome from Egypt’s Old Kingdom period, revealing unexpected genetic connections between early dynastic Egypt and Mesopotamian populations. The study, published in Nature, fills a critical 3,000-year gap in our understanding of ancient Egyptian population genetics.
Scientists analyzed 2,762 Indian genomes revealing 50,000 years of evolutionary history and discovered over 160,000 new disease-causing genetic variants that could transform medical care for billions globally.
New research identified altered microRNA expression patterns in female OCD patients, with miR-132 increased and miR-125b-5p decreased compared to healthy controls. Higher plasma serotonin levels and positive correlation between dopamine and symptom severity suggest potential biomarkers for OCD diagnosis.
Leiden Bio Science Park’s biotech ecosystem with 215+ organizations employing 25,000 professionals needs specialized preclinical CRO services to accelerate drug discovery. Anilocus provides comprehensive research support from Leiden University spinouts to established pharmaceutical companies like Janssen and Bristol Myers Squibb navigating EMA and FDA requirements in the Netherlands’ largest life
Houston’s biotech ecosystem with 1,100+ life sciences companies and 106,000 Texas Medical Center employees needs specialized preclinical CRO services to accelerate drug discovery. Anilocus provides comprehensive research support from university spinouts to established pharmaceutical companies like Marker Therapeutics navigating FDA requirements in America’s largest medical complex and fastest-growing biotechnology hub.
Heidelberg’s biotech ecosystem with 450 employees across 30 biotechnology companies, anchored by world-class research institutions DKFZ and EMBL, needs specialized preclinical CRO services. Anilocus provides comprehensive research support from university spinouts to established pharmaceutical companies like Heidelberg Pharma navigating EMA and FDA requirements in Germany’s leading life sciences cluster in
Dublin’s thriving biotech ecosystem with 90+ pharmaceutical companies employing 50,000 people generates €99.9 billion in exports, requiring specialized preclinical CRO services. Anilocus provides comprehensive research support from Trinity College Dublin spinouts to established pharmaceutical giants like Pfizer and Novartis navigating EMA and FDA requirements in Ireland’s world-leading life sciences hub.
Dubai-Abu Dhabi’s emerging biotech ecosystem with 400+ companies and 4,000 professionals in Dubai Science Park plus Abu Dhabi’s $25.6 billion HELM cluster need specialized preclinical CRO services. Anilocus provides comprehensive research support from UAE university spinouts to established pharmaceutical giants like PureHealth and G42 Healthcare navigating regulatory requirements in the
Copenhagen’s 350+ biotech companies and 44,000 life sciences employees in Medicon Valley need specialized preclinical CRO services to accelerate drug discovery. Anilocus provides comprehensive research support to Denmark’s biotech researchers from University of Copenhagen spinouts to established pharmaceutical giants like Novo Nordisk and Lundbeck navigating EMA and FDA requirements in
Bold ideas and breakthrough research. Expert analysis on the innovations and drug development for the most important people in the world: patients.
Use this form to send your questions to our research team about our preclinical contract research services.
We are here to help!
